Study on ovarian cancer development mediated by intestinal microbiology dysbiosis and its mechanism

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000034627

Enrollment

Unknown

Registered

2020-07-12

Start date

2020-08-01

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Control:Null

Ovarian benign tumor:Null

Ovarian cancer:Null

Eligibility

Sex/Gender

Female

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Clinically stable, and aged 18-75 years old; 2. Epithelial ovarian cancer (serous adenocarcinoma, mucinous adenocarcinoma, endometrioid adenocarcinoma, etc.) was confirmed by puncture pathology or highly suspected by imaging, and confirmed by postoperative pathology; 3. Patients did not receive relevant treatment before; 4. Signed informed Consent.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic inflammatory or infectious diseases (such as rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, etc.), blood diseases; 2. Patients complicated with serious heart, lung, kidney, liver dysfunction and metabolic diseases; 3. Patients with known immunosuppressive diseases (such as HIV infection), or taking immunosuppressive drugs; 4. Those who have received antibiotics or other drugs in the last three months.

Design outcomes

Primary

Measure	Time frame
Gut microbiota;Blood routine examination;Pathology report;	—

Secondary

Measure	Time frame
General information;	—

Countries

China

Contacts

Public ContactQi Chen

The Second Affiliated Hospital of Nanchang University

ndefy97010@ncu.edu.cn+86 13807912933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026